Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Accumulating evidence has revealed that the gut microbiota influences the effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients. As a part of the human microbiome, Helicobacter pylori (H. pylori) was reported to be associated with reduced effectiveness of anti-PD1 immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Che, Hebin, Xiong, Qi, Ma, Jinxia, Chen, Shixue, Wu, Huan, Xu, Hongli, Hou, Baicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389789/
https://www.ncbi.nlm.nih.gov/pubmed/35986342
http://dx.doi.org/10.1186/s12885-022-10004-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389789/
https://www.ncbi.nlm.nih.gov/pubmed/35986342
http://dx.doi.org/10.1186/s12885-022-10004-9

Ejemplares similares